Postmenopausal hormone therapy
may have an added benefit of reducing your risk of developing glaucoma.
Researchers reporting a study in JAMA
Ophthalmology found that taking
estrogen only postmenopausal hormone (PMH) treatment may help specifically
reduce the risk for primary open-angle glaucoma (POAG), the most common type of
glaucoma. By reviewing data from 152,163 women 50 years or older the
researchers found that 1.9 percent of enrollees developed POAG. Each additional
month of use of PMH containing estrogen
only was associated with a 0.4 percent reduced risk for POAG whereas each
additional month of use of estrogen + progesterone or estrogen + androgen
hormones did not affect risk for POAG. This is interesting information and will
most likely be the subject of future research to understand how it might be
used to develop new treatment options for primary open angle glaucoma (POAG).
If you or someone you know is concerned about glaucoma, has
any risk factors for glaucoma or needs to schedule a glaucoma eye exam please
call Alabama Eye & Cataract Center at 205-930-0930,
visit Alabama Eye & Cataract Center or
http://www.facebook.com/michelsonlaservision.
Alabama Eye & Cataract Center is leading eye care
center in Birmingham located at UAB-Highlands, 1201 11th Avenue S, Suite 501,
Birmingham, Alabama 35205
